Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annelie Vulink"'
Autor:
Vivianne C. G. Tjan-Heijnen, Paul Hamberg, Vahram Hovsepjan, Aeilko H. Zwinderman, Mariette Labots, Frits I. Mulder, Laurens V. Beerepoot, Harry R. Büller, Albert J. ten Tije, Thijs F. van Haaps, Roos J van Geffen, Martijn P. Lolkema, Maartje Los, Hanneke W. M. van Laarhoven, Neeltje Steeghs, Bart Ferwerda, Noori A.M. Guman, Filip de Vos, Annelie Vulink, Pieter Willem Kamphuisen, Nick van Es, Geert A. Cirkel
Publikováno v:
Journal of thrombosis and haemostasis, 19(12), 2974-2983. Wiley-Blackwell
Guman, N A M, van Geffen, R J, Mulder, F I, van Haaps, T F, Hovsepjan, V, Labots, M, Cirkel, G A, Y. F. L. de Vos, F, ten Tije, A J, Beerepoot, L V, Tjan-Heijnen, V C G, van Laarhoven, H W M, Hamberg, P, Vulink, A J E, Los, M, Zwinderman, A H, Ferwerda, B, Lolkema, M P J K, Steeghs, N, Büller, H R, Kamphuisen, P W & van Es, N 2021, ' Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer ', Journal of Thrombosis and Haemostasis, vol. 19, no. 12, pp. 2974-2983 . https://doi.org/10.1111/jth.15503
Journal of Thrombosis and Haemostasis, 19(12), 2974-2983. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis, 19(12), 2974-2983. Wiley
Journal of Thrombosis and Haemostasis, 19(12), 2974-2983. Wiley-Blackwell
Guman, N A M, van Geffen, R J, Mulder, F I, van Haaps, T F, Hovsepjan, V, Labots, M, Cirkel, G A, Y. F. L. de Vos, F, ten Tije, A J, Beerepoot, L V, Tjan-Heijnen, V C G, van Laarhoven, H W M, Hamberg, P, Vulink, A J E, Los, M, Zwinderman, A H, Ferwerda, B, Lolkema, M P J K, Steeghs, N, Büller, H R, Kamphuisen, P W & van Es, N 2021, ' Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer ', Journal of Thrombosis and Haemostasis, vol. 19, no. 12, pp. 2974-2983 . https://doi.org/10.1111/jth.15503
Journal of Thrombosis and Haemostasis, 19(12), 2974-2983. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis, 19(12), 2974-2983. Wiley
Journal of Thrombosis and Haemostasis, 19(12), 2974-2983. Wiley-Blackwell
Background: The Khorana score is a validated tool to identify cancer patients at higher risk of venous thromboembolism (VTE). Objective: We compared its predictive performance to that of the clinical PROTECHT and the polygenic 5-SNP scores in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023500bbc942d7e6cdeee1e0b95d8151
https://pure.amc.nl/en/publications/evaluation-of-the-khorana-protecht-and-5snp-scores-for-prediction-of-venous-thromboembolism-in-patients-with-cancer(a3d7bd2d-5400-4ed2-b6d5-98bb01c97b86).html
https://pure.amc.nl/en/publications/evaluation-of-the-khorana-protecht-and-5snp-scores-for-prediction-of-venous-thromboembolism-in-patients-with-cancer(a3d7bd2d-5400-4ed2-b6d5-98bb01c97b86).html
Autor:
Annelieke Lemij, Willeke van der Plas-Krijgsman, Esther Bastiaannet, Jos Merkus, Thijs van Dalen, Annelie Vulink, Leander van Gerven, Onno Guicherit, Eugenie Linthorst-Niers, Titia Lans, Carmen van der Pol, Lynda Wyld, Jenna Morgan, Johanneke Portielje, Nienke de Glas, Gerrit Jan Liefers
Publikováno v:
European Journal of Surgical Oncology. 48:e32-e33
Autor:
Christiaan van der Leij, Krijn P. van Lienden, Jan J. J. de Vries, Nomdo S Renken, F. Daams, Ronald M. van Dam, C. Yung Nio, M. Liem, Thomas L. Bollen, Geert-Jan Creemers, Steffi J Rombouts, Judith de Vos-Geelen, Gijs A. Patijn, Maartje Los, Sebastiaan Festen, I. Quintus Molenaar, J. Nederend, Derk Jan A. de Groot, Rutger C G Bruijnen, Jan Willem B. de Groot, Joost G Blomjous, Leonie J. M. Mekenkamp, John J. Hermans, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Susana I S Patuleia, Johanna W. Wilmink, Thijs J Schouten, Maaike E Verweij, Lilly J H Brada, Hjalmar C. van Santvoort, Emile D. Kerver, Vincent E de Meijer, J.F.M. Pruijt, Annelie Vulink, Koop Bosscha, Frank J. Wessels, Maarten S. van Leeuwen, Marc G. Besselink, Marco B. Polee, Olivier R. Busch, Martijn R. Meijerink, M.S. Walma, Martijn W J Stommel
Publikováno v:
European Journal of Surgical Oncology, 47(3), 699-707. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137
European Journal of Surgical Oncology, 47, 699-707
European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 3, pp. 699-707
European Journal of Surgical Oncology, 47(3), 699-707. W.B. Saunders Ltd
for the Dutch Pancreatic Cancer Group 2021, ' Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer : A multicenter prospective cohort ', European Journal of Surgical Oncology, vol. 47, no. 3, pp. 699-707 . https://doi.org/10.1016/j.ejso.2020.11.137
European Journal of Surgical Oncology, 47, 699-707
European journal of surgical oncology, 47(3), 699-707. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47, 3, pp. 699-707
Introduction: Since current studies on locally advanced pancreatic cancer (LAPC) mainly report from single, high-volume centers, it is unclear if outcomes can be translated to daily clinical practice. This study provides treatment strategies and clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af8a66a9183508390e581990d356d615
https://doi.org/10.1016/j.ejso.2020.11.137
https://doi.org/10.1016/j.ejso.2020.11.137
Autor:
B.M. Zonderhuis, Tom C.J. Seerden, N. C. M. van Huijgevoort, E. J. M. van Geenen, Leonie J. M. Mekenkamp, Koop Bosscha, C. Wientjes, R. C. Verdonk, Gijs A. Patijn, Rutger Quispel, L.G.M. van der Geest, Lodewijk A.A. Brosens, Frank J. Wessels, M. G. H. van Oijen, O.R.C. Busch, A. Bogte, Johanna W. Wilmink, Emile D. Kerver, Lieke Hol, Tara M. Mackay, J. Verheij, H. Lubbinge, Marjolein Y.V. Homs, I. Q. Molenaar, A.J. ten Tije, B. C. M. Haberkorn, Jennifer M.J. Schreinemakers, V E de Meijer, C.H. van Werkhoven, H.C. van Santvoort, Saskia A C Luelmo, Wouter L. Curvers, C.H.J. van Eijck, F.J. Smits, J. E. van Hooft, F. G. I. van Vilsteren, L. M. J. W. van Driel, F. Wit, Derk Jan A. de Groot, J. T. Haver, Bert A. Bonsing, H. Schut, I.H.J.T. de Hingh, J.W.B. de Groot, N. Haj Mohammad, H.W.M. van Laarhoven, H. Bos, Niels G. Venneman, M. den Dulk, L.B. van Rijssen, Martijn W J Stommel, Sebastiaan Festen, Tessa E H Römkens, Chantal V Hoge, Annelie Vulink, J. de Vos-Geelen, Gjm Hemmink, Marc Jacobs, G.J.M. Creemers, Anouk E J Latenstein, S. van Dieren, Marc G. Besselink, Mike Liem, E. van der Harst, Maartje Los
Publikováno v:
MacKay, T M, Smits, F J, Latenstein, A E J, Bogte, A, Bonsing, B A, Bos, H, Bosscha, K, Brosens, L A A, Hol, L, Busch, O R C, Creemers, G J, Curvers, W L, Den Dulk, M, Van Dieren, S, Van Driel, L M J W, Festen, S, Van Geenen, E J M, Van Der Geest, L G, De Groot, D J A, De Groot, J W B, Haj Mohammad, N, Haberkorn, B C M, Haver, J T, Van Der Harst, E, Hemmink, G J M, De Hingh, I H, Hoge, C, Homs, M Y V, Van Huijgevoort, N C, Jacobs, M A J M, Kerver, E D, Liem, M S L, Los, M, Lubbinge, H, Luelmo, S A C, De Meijer, V E, Mekenkamp, L, Molenaar, I Q, Van Oijen, M G H, Patijn, G A, Quispel, R, Van Rijssen, L B, Römkens, T E H, Van Santvoort, H C, Schreinemakers, J M J, Schut, H, Seerden, T, Stommel, M W J, Ten Tije, A J, Venneman, N G, Verdonk, R C, Verheij, J, Van Vilsteren, F G I, De Vos-Geelen, J, Vulink, A, Wientjes, C, Wit, F, Wessels, F J, Zonderhuis, B, Van Werkhoven, C H, Van Hooft, J E, Van Eijck, C H J, Wilmink, J W, Van Laarhoven, H W M & Besselink, M G 2020, ' Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1) : A multicenter stepped-wedge cluster randomized controlled trial ', Trials, vol. 21, no. 1, 334 . https://doi.org/10.1186/s13063-020-4180-z
Trials, 21
Trials
Trials, 21(1):334. BioMed Central
TRIALS, 21(1):334. BMC
Trials, 21(1). BMC
Trials, 21(1). BioMed Central Ltd.
Trials, 21, 1
Trials, Vol 21, Iss 1, Pp 1-18 (2020)
Trials, 21(1). BioMed Central
Trials, 21(1):334. BioMed Central Ltd
Trials, 21
Trials
Trials, 21(1):334. BioMed Central
TRIALS, 21(1):334. BMC
Trials, 21(1). BMC
Trials, 21(1). BioMed Central Ltd.
Trials, 21, 1
Trials, Vol 21, Iss 1, Pp 1-18 (2020)
Trials, 21(1). BioMed Central
Trials, 21(1):334. BioMed Central Ltd
Background Pancreatic cancer has a very poor prognosis. Best practices for the use of chemotherapy, enzyme replacement therapy, and biliary drainage have been identified but their implementation in daily clinical practice is often suboptimal. We hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc579abe0c6c89b5b53855fba26161ce
https://research.vumc.nl/en/publications/9cf33a71-45a4-4cac-b43f-782103a25fe1
https://research.vumc.nl/en/publications/9cf33a71-45a4-4cac-b43f-782103a25fe1
Autor:
Rhodé M Bijlsma, Stefan Sleijfer, Daan ten Bokkel Huinink, Emile E. Voest, Annelie Vulink, Annelien L. Bredenoord, Neeltje Steeghs, Theo van Voorthuizen, Els Witteveen, Martijn P. Lolkema, Joan B. Heijns, Margreet G. E. M. Ausems, Roel H. P. Wouters, Hester van Cruijsen, Laurens V. Beerepoot, Anne M. May, Hester Wessels
Publikováno v:
ESMO open, 5(2)
ESMO Open, 5(2):e000619. BMJ Publishing Group
ESMO Open
ESMO Open, 5(2):e000619. BMJ Publishing Group
ESMO Open
Background In precision medicine, somatic and germline DNA sequencing are essential to make genome-guided treatment decisions in patients with cancer. However, it can also uncover unsolicited findings (UFs) in germline DNA that could have a substanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f027538db24b4c7c087b2ec614085b1e
https://dspace.library.uu.nl/handle/1874/396020
https://dspace.library.uu.nl/handle/1874/396020
Autor:
Jacqueline A E Langius, M.A.E. de van der Schueren, A.J. ten Tije, Annelie Vulink, A. Haringhuizen, H.J. van der Vliet, Aart Beeker, Johannes Berkhof, Henk M.W. Verheul, A. van der Werf
Publikováno v:
Clinical Nutrition Supplements, 39, 10, pp. 3005-3013
van der Werf, A, Langius, J A E, Beeker, A, Ten Tije, A J, Vulink, A J, Haringhuizen, A, Berkhof, J, van der Vliet, H J, Verheul, H M W & de van der Schueren, M A E 2020, ' The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy : A randomized controlled trial ', Clinical Nutrition, vol. 39, no. 10, pp. 3005-3013 . https://doi.org/10.1016/j.clnu.2020.01.009
Clinical Nutrition Supplements, 39, 3005-3013
Clinical Nutrition, 39(10), 3005-3013. Churchill Livingstone
Clinical Nutrition, 39, 3005-3013
van der Werf, A, Langius, J A E, Beeker, A, Ten Tije, A J, Vulink, A J, Haringhuizen, A, Berkhof, J, van der Vliet, H J, Verheul, H M W & de van der Schueren, M A E 2020, ' The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy : A randomized controlled trial ', Clinical Nutrition, vol. 39, no. 10, pp. 3005-3013 . https://doi.org/10.1016/j.clnu.2020.01.009
Clinical Nutrition Supplements, 39, 3005-3013
Clinical Nutrition, 39(10), 3005-3013. Churchill Livingstone
Clinical Nutrition, 39, 3005-3013
Contains fulltext : 229520.pdf (Publisher’s version ) (Closed access) BACKGROUND & AIMS: A low muscle mass before start of treatment and loss of muscle mass during chemotherapy is related to adverse outcomes in patients with cancer. In this randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6ecc5dcc4fbfeaabb4a712d3b5894bc
https://hdl.handle.net/2066/229520
https://hdl.handle.net/2066/229520
Autor:
A. Haringhuizen, H.J. van der Vliet, H. M. W. Verheul, M.A.E. de van der Schueren, J.A.E. Langius, Annelie Vulink, Aart Beeker, A.J. ten Tije, A. van der Werf, H.J. Berkhof
Publikováno v:
Clinical Nutrition. 38:S195
Publikováno v:
Advances in cancer research. 99
Since their discovery, there has been significant progress in the understanding of dendritic cell (DC) biology. Their capacity for priming an immune response against pathogens and cancers has been exploited clinically. However, the objective response